2021 article

When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest

Wood, S., & Schulman, K. (2021, June 2). JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

By: S. Wood n  & K. Schulman *

MeSH headings : Apathy; Health Promotion / methods; Humans; Patient Acceptance of Health Care / psychology; Vaccination / psychology; Vaccination Refusal
TL;DR: The COVID-19 vaccine is arguably the most important new product of 2021, but until recently, vaccine promotion efforts have not addressed the full implications of marketing a single product to a large, heterogeneous population. (via Semantic Scholar)
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: June 10, 2021

Even before COVID-19 vaccines were available, different interest levels in vaccination across the US were noted.1 Populations with less interest in vaccination were quickly considered vaccine hesitant, and public health campaigns have primarily, and understandably, focused on reaching persons anxious about vaccine safety, vaccine-related adverse effects, or both. But while vaccine anxiety is an important hurdle to overcome, the assumption that all segments of the population with low interest in vaccination are hesitant is a misconception. The COVID-19 vaccine is arguably the most important new product of 2021, but until recently, vaccine promotion efforts have not addressed the full implications of marketing a single product to a large, heterogeneous population.2 From a marketing perspective, disinterest in vaccination from some segments of the population is unsurprising and reflects typical innovation-adoption patterns in which half of the market is usually slow to make a choice. This appears to be a description of the sizeable segment of the population that has not participated in public vaccination campaigns. News reports now recognize the challenges of vaccinating an entire population, but the sophistication of the current collective vaccine-promotion strategies have evolved more slowly and focus on alleviating vaccine